Diosmin
Product Description
Sichuan Xieli Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:1
-
Employees:250 - 499
Company types
Primary activities
Specifications
Sichuan Xieli Pharmaceutical Co., Ltd.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:1
-
Employees:250 - 499
Company types
Primary activities
More Products from Sichuan Xieli Pharmaceutical Co., Ltd. (37)
-
Product Capecitabine
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes capecitabine. It belongs to antitumor apis category. It is antitumor api. Contact us for more information. -
Product Chlorogenic acid
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes chlorogenic acid. It belongs to extracts for api category. It is etracting from honeysuckle flower and eucommia ulmoide. It has widely effect on antibacterial. Contact us for more information. -
Product Chondroitin sulphate
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes chondroitin sulphate. It belongs to extracts for api category. It work synergistically to krrp tendeons,ligaments ,arteries,skin and other tissue strong and resilient. Contact us for more information. -
Product Cystine
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes cystine. It belongs to extracts for api category. It is used in the treatment of the reduction of white blood cell, coronary and prevent fatty liver and liver. Contact us for more information. -
Product Cytisine
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes cytisine. It belongs to extracts for api category. It can be used as first-aid medicine, cough medicine and smoking deterent. Recent studies indicate that the cytisine has lots of pharmacological effects including anti-arrh... -
Product Dihydroartemisinin
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes dihydroartemisinin. It belongs to antimalaria apis category. It has quickly killing effect on malaria parasites in the red period and also can control clinical seizures and symptoms rapidly. Contact us for more information. -
Product Docetaxel
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes docetaxel. It belongs to antitumor apis category. It is an api belongs to paclitaxel antitumor series, which interferes the cells's divide or the microtubule during the division to have the function of antitumor. Contact us... -
Product Exemestane
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes exemestane. It belongs to antitumor apis category. It is the second generation of aromatic enzyme inhibitor and used in the treatment of metastatic breast cancer and used as adjuvant therapy for early breast cancer. Contact... -
Product Ginkgo extract
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes ginkgo extract. It belongs to cardiovascular apis category. It can inhibit the formation of microthrombosis, change the blood rheology, decrease blood visicosity and improve microcirculation. Contact us for more information. -
Product Hesperidin
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes hesperidin. It belongs to cardiovascular apis category. It can decrease the permeability and fragility of capillaries, and treat hypertension and hemorrhagic disease of blood capillary with other medicine. Contact us for mo... -
Product Ibandronate sodium
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes ibandronate sodium. It belongs to antitumor apis category. It is used in treating malignant high calcium blood and anti-osteoporosis drug. Contact us for more information. -
Product Imatinib mesylate
Sichuan xieli pharmaceutical co. Ltd offers a wide range of products which includes imatinib mesylate. It belongs to antitumor apis category. It is used to treat patients with chronic myeloid leukemia in cml blast crisis, accelerated phase or chronic phase who have a failure treatment after treatment witn ...